NCT01061749 2016-01-25Selumetinib and Cixutumumab in Treating Patients With Advanced Solid MalignanciesNational Cancer Institute (NCI)Phase 1 Completed30 enrolled
NCT00888134 2016-01-15Selumetinib in Cancers With BRAF MutationsNational Cancer Institute (NCI)Phase 2 Completed28 enrolled 9 charts